Cold Chain Logistics Market Size and Overview
The cold chain logistics market, valued at USD 4.13 billion in 2025, is projected to reach USD 4.18 billion in 2026 and USD 4.32 billion by 2030, with a 0.85% CAGR during the forecast period 2026 to 2030. Over 95% of all approved biologics and 90% of all vaccines are cold chain dependent.
To learn more about this report, request a free sample copy
According to the data presented by the WHO, the current global vaccination coverage is nearly 85%; however, it has been reported that 25% of vaccines are damaged due to cold chain malfunction (improper distribution and shipping). In some countries, about 80% of the drugs are estimated to lose their potency due to inadequate temperature control during their cold chain transportation.
For some vaccines, even the slightest variations in temperature / storage conditions can adversely alter product integrity and / or viability. In this context, it is worth mentioning that there are several vaccines being developed against COVID-19; given the nature of the pathogen, these aforementioned product candidates are likely to be cold chain dependent. For example, the synthetic mRNA-based COVID vaccine being developed by Pfizer (which is, so far, the most promising candidate) is required to be stored at -70°C (-94°F) or lower. This fundamentally complicates the use and cold chain distribution for vaccines in temperate / equatorial regions, where distances between populated regions are vast and a proper cold chain infrastructure is lacking. Other healthcare products that need to be shipped / stored under low temperatures include aerosols, blood plasma, and certain diagnostics kits.
Considering the projected growth of the global population, it is likely that the demand for vaccines will indubitably increase. Consequently, well-defined cold chain infrastructure and established vaccine supply networks are crucial to the success of global level immunization initiatives. This is also true for all vaccination programs for COVID-19, which is an immediate and exigent concern. In other words, the biggest challenge in cold chain logistics is lack of / inadequate infrastructure to support the cold chain storage and / or transportation of vaccines. Moreover, connected cold chain solutions have been observed to offer a variety of advantages over conventional methodologies, such as automation of most of the steps and elimination of human handling errors that are associated with human intervention.
Over time, there has been significant consolidation in this industry, with stakeholders expanding their respective facilities / capabilities, and also making strategic acquisitions to better serve their growing clientele. Further, the logistics service providers are focused on devising and implementing flexible business strategies and technical advancements in order to cope with increased inflow of patients. The countries are also preparing for sustainable cold chain storage and distribution / supply of COVID-19 vaccine to different parts of globe, as the reliance on cold chain facilities for coronavirus vaccine is expected to increase substantially. The above mentioned factors will continue to drive the growth in global cold chain logistics market over the forecast period.
Key Companies in Cold Chain Logistics Market
Examples of key cold chain logistics companies engaged in cold chain logistics market (which have also been profiled in this market report; the complete list of cold chain logistics companies is available in the full report) include Cryoport, DHL Express, GAC, Lynden International Logistics, PAREXEL, United Parcel Service and Yusen Logistics. This market report includes an easily searchable excel database of all the cold chain logistics companies providing cold chain logistics for vaccines, worldwide.
Recent Developments in Cold Chain Logistics Market
Several recent developments have taken place in the field of cold chain logistics market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
- In February 2026, Rinac Systems highlighted expanded Indian government subsidy schemes reimbursing 35% of project costs in general regions and up to 50% in hilly or Northeastern areas. These support integrated cold chain infrastructure including cold stores, pre-cooling, and refer to reducing agrifood losses and driving private investment in nationwide cold chain logistics.
- In March 2025, Cold Chain Technologies announced the acquisition of GCCS, a provider of passive cold chain packaging solutions in Australia and India, expanding its Asia-Pacific manufacturing footprint and life sciences logistics capabilities.
Cold Chain Logistics Market Trends and Scope
The ‘Cold Chain Logistics Market for Vaccines: Industry Trends and Global Forecasts, till 2030, market report features an extensive study of the current market landscape, market size, market share, market growth, market forecast, market outlook and future opportunities of the cold chain logistics market. Further, the market research report underlines an in-depth analysis of players engaged in offering cold chain logistics services for vaccines.
Amongst other elements, the market research report features:
- A detailed assessment of the current market landscape of cold chain logistics companies that claim to offer cold chain logistics services for vaccines based on a number of relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of service(s) offered (storage, packaging, and transportation), mode of transportation used (ground, air, and ocean), holding temperature range (ambient, refrigerated, frozen, and deep frozen / cryogenic), type of packaging method adopted (dry ice, liquid nitrogen, and gel packs), type of container used (active and passive containers), end-user (healthcare and non-healthcare), availability of capabilities for transport of COVID-19 vaccine, location of cold chain facilities.
- A contemporary market trend analysis, which includes [A] a tree map representation, comparing industry players on the basis of holding temperature range and company size, [B] a tree map representation, comparing industry players on the basis of holding temperature range and geographical activity, [C] a heat map representation comparing players on the basis of location of cold chain facility and geographical activity, [D] a grid representation which highlights the distribution of players based on mode of transportation, type of container and geographical activity, [E] a world map representation presenting the regional distribution of players engaged in cold chain logistics market based on the location of their respective headquarters, and [F] a comparative grid representation to highlight the historical and current market landscape based on holding temperature range, mode of transportation, and geographical activity.
- An insightful company competitiveness analysis, highlighting prominent logistics service providers, taking into consideration their supplier strength (in terms of experience of the service provider), and capabilities related to cold chain logistics (such as type of container, type of service(s) offered, holding temperature range, mode of transportation and location of cold chain facility).
- Elaborate profiles of prominent service providers (shortlisted on the basis of the company competitiveness analysis) engaged in cold chain logistics market. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective portfolios for cold chain services, recent developments, and an informed future outlook.
- An elaborate discussion on the various regulatory guidelines that have been laid down by major regulatory bodies (such as European Medicines Agency (EMA), United States Food and Drug Administration (USFDA), Health Canada (HC), International Air Transport Association (IATA), International Safe Transit Association (ISTA), United States Pharmacopeia (USP), and World Health Organization (WHO)), specific to cold chain management. In addition, it features an insightful analysis, comparing these regulatory authorities based on the guidelines issued by them for different stages of the cold chain.
- An analysis of the recent developments and initiative (partnerships, expansions, and initiatives) that have been undertaken in the cold chain logistics market for vaccines, since 2016. The chapter also includes details on the initiatives taken by big-pharma players in the last few years.
- A detailed estimation of the likely demand for logistics services for COVID-19 vaccines and other vaccines (including over 15 types of mandatory and optional vaccines), considering the contributions from both clinical and commercially available products for infants and adults, since 2021.
- A detailed discussion on the upcoming tools / technologies (such as integration of automation and robotics, cloud services, blockchain in healthcare, AI in oncology and other such advanced technical solutions) in the field of cold chain logistics and their likely impact on the future evolution of this market.
- An insightful discussion on how the recent COVID-19 pandemic is likely to impact the cold chain logistics market for vaccines, along with information on the key initiatives undertaken by service providers to overcome the challenges faced due to the pandemic.
The key objective of cold chain logistics market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for cold chain logistics market during the forecast period. We have developed an informed estimate of the financial evolution of the market, over the forecast period till 2030. The market report also provides details on the likely distribution of the current and forecasted opportunity across [A] type of vaccines (COVID-19 and other vaccines), [B] holding temperature range (refrigerated, frozen, and cryogenic), [C] scale of operation (clinical and commercial), [D] type of container (active and passive containers), [E] end-user (industry and non-industry), and [F] key geographical regions (North America, Europe, Asia, Latin America (LATM), Middle East and North Africa (MENA) and Rest of the World). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the industry’s evolution.
The opinions and insights presented in this study were also influenced by discussions conducted with several stakeholders in cold chain logistics market. The market research report features detailed transcripts of interviews held with the following individuals (in alphabetical order):
- Co-founder, Germany-based Large Company
- Deputy General Manager, India-based Small Company
- Marketing Communications Manager, Russia-based Large Company
- Health Specialist, Cold Chain Logistics, US-based Very Large Organization
- Supply Chain Manager, Saudi Arabia-based Large Company
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.
Frequently Asked Questions
Question 1: What is cold chain logistics?
Answer: Cold chain logistics in pharmaceuticals refer to supply / transportation chain dealing with temperature sensitive vaccines and biologics.
Question 2: How big is the cold chain logistics market?
Answer: The cold chain logistics market size is estimated to be worth $4.18 billion in 2026.
Question 3: Who are the leading companies in the cold chain logistics market?
Answer: Examples of key companies engaged in cold chain logistics market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Cryoport, DHL Express, GAC, Lynden International Logistics, PAREXEL, United Parcel Service and Yusen Logistics.
Question 4: How many companies are currently engaged in the cold chain logistics market?
Answer: Over 75 companies are currently engaged in the cold chain logistics market, offering necessary expertise in the transportation of vaccines.
Question 5: How many vaccines are subjected to heat degradation during shipping activities?
Answer: Close to 25% of the packaged vaccines are subjected to degradation due to unfavorable temperature conditions during shipping activities.
Question 6: How many logistics providers have capabilities for cryogenic transportation?
Answer: 13% of the captured logistics providers have capabilities for cryogenic transportation.
